This interaction activates intracellular signaling pathways, including the AKT and MAPK pathways, via β-arrestin-mediated signaling, thereby contributing to tumor progression and modulation of the tumor microenvironment (3, 4). The gene discussed is AKT1; the disease is neoplasm.